Anticoagulation in Atrial Fibrillation and Rheumatic Heart Disease-Reference-Cited by-同舟云学术

Anticoagulation in Atrial Fibrillation and Rheumatic Heart Disease

Published:2022-09-15 Issue:11 Volume:387 Page:1036-1038
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Lip Gregory Y.H.¹

Affiliation:

1. From the Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University, and Liverpool Heart and Chest Hospital — all in Liverpool, United Kingdom; and the Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMe2210187

Reference12 articles.

1. Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)

2. Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation

3. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

4. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

5. Effect of low-intensity warfarin anticoagulation on level of activity of the hemostatic system in patients with atrial fibrillation. BAATAF Investigators.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioembolic Stroke;Neurologic Clinics;2024-08

2. A qualitative study exploring patient experiences and opinions of warfarin patient self‐management in the US healthcare system;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-12-26

3. Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?;Seminars in Thrombosis and Hemostasis;2023-05-09